Lykos Therapeutics fka MAPS PBC
5 known investors
Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder. The company applies decades of evidence-based research to create new therapeutic approaches for patients with unmet mental healthcare needs.